NY Financial Regulator Files Insurance Fraud Charges Against Opioid Manufacturers
New York’s Department of Financial Services (DFS) has filed insurance fraud charges against opioid manufacturers Teva Pharmaceuticals and Allergan Plc.
According to a statement from Governor Andrew Cuomo, the DFS alleged in its filing that both Teva and Allergan took part in fraudulent marketing and promotional campaigns – campaigns which misrepresented the safety and effectiveness of opioid drugs.
Reuters reached out to both Teva and Allergan for comment, but neither were able to immediately respond.
Read more: Healthcare fraud tops $2 billion for tenth year in a row
In 2019, opioid manufacturer Insys Therapeutics paid $195 million to settle civil allegations that it gave kickbacks to physicians and nurses, bribing them to prescribe the company’s own drug Subsys for patients.
The Fundamentals Of Asset-Liability Management
Author: Ricardo Goulart ... Read more
Enhancing Shareholder Value Through Fiscal Responsibility
Author: Brett Hurll &nb... Read more
The Importance Of Life Insurance In Financial Planning
Life is unpredictable, underscoring the cardinal rule within the realm of finances, "expect the unexpected.” Life insu... Read more
How Insurance Companies Determine Premiums
Decoding the labyrinth of how insurance companies determine premiums isn't as daunting as it seems. Essentially, insuran... Read more
Different Types Of Insurance And Their Benefits
Engaging with the intricate world of finance presents an age-old certainty - "Different types of insurance and their ben... Read more
Machine Learning In Risk Assessment For B2B Loans
Risky business, and even riskier decisions – that's where machine learning in risk assessment for B2B loans finds a pl... Read more